What is CrossRoads Extremity Systems?
CrossRoads Extremity Systems, through its specialization in minimally invasive bunion surgery, offers an advanced procedure that utilizes smaller incisions than traditional methods. This innovative approach facilitates immediate post-operative ambulation with a specialized shoe, promoting a faster patient recovery. The company is dedicated to providing effective bunion correction and pain relief, with its solutions covered by most insurance policies and accessible across the U.S. for individuals seeking cutting-edge foot surgery.
How much funding has CrossRoads Extremity Systems raised?
CrossRoads Extremity Systems has raised a total of $4.1M across 3 funding rounds:
Private Equity
$3M
Debt
$350K
Debt
$810K
Private Equity (2018): $3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2021): $810K supported by PPP
What's next for CrossRoads Extremity Systems?
The recent major strategic investment signals a pivotal phase for CrossRoads Extremity Systems, likely enabling further expansion of its minimally invasive surgical techniques and market reach. This capital infusion is expected to fuel research and development for next-generation extremity solutions, enhance operational scaling, and potentially broaden its service offerings to address a wider range of orthopedic conditions. The company's focus on patient recovery and insurance coverage positions it for continued growth and adoption in the competitive medical device landscape.
See full CrossRoads Extremity Systems company page
